KDR and breast cancer: Similarly, although direct interaction of KDR with hsa-miR-429 has not been demonstrated, it was observed that hsa-miR-429 suppresses breast cancer invasion by inhibiting the Wnt/β-catenin pathway through potentially targeting SOX2, CBL, FN1, KDR, KLF4, NR3C1, QK1, RBFOX3, SYNJ1, and VEGFA detected by CytoHubba algorithm in Cytoscape (Zhang et al., 2020).